Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Infervision: Our AI Detects Deadly Coronavirus via CT Lung Screening
Infervision: Our AI Detects Deadly Coronavirus via CT Lung Screening
A doctor using Infervision’s interface to detect unusual lung formations. Image: Credit to Infervision
Associated Company
InferVision InferVision

Infervision (推想科技) described its coronavirus detection model as working through CT lung screening. This means that the new model detects ground-glass opacities (GGO) in the lung that may later be confirmed as one of the complications of the virus.

The firm's model has already been used by Wuhan Tongji Hospital, one of the frontline hospitals that has been fighting with the epidemic in Wuhan. It is set to be deployed in multiple other hospitals in the near future, Infervision said. 

“It serves as a surrogate to PCR diagnostic as the lab capacities aren't enough to keep up with the rising number of suspected cases in the afflicted regions," added the company.

Another diagnostics solution support for the rising crisis was launched by Shenzhen-based genomics giant BGI Genomics (300676: SH) on January 28. The company's stocks opened around 10% up as the mainland's stock markets open on January 3, 2020.

“The new coronavirus may cause infections with no symptoms and sicken otherwise healthy people,” postulated the Lancet, showing how hard it is presently for hospitals in Wuhan, which are racing against time to diagnose large numbers of patients.

The new diagnostic solutions possess tremendous importance for the afflicted region, considering the symptoms of the new virus are similar to other fast-spreading diseases like flu, complicating the process and creating excess demand thanks to a large number of concerned patients who need to be assessed. "Symptomatic patients are piling up in the hospital – AI can help triage the patients quickly," said the firm. "Patients have been seen without any noticeable symptoms like fever or cough, but showing large GGOs in the lung,"

The Beijing-based private firm had long been drawing the attention of wealthy venture capitalists, including Qiming Venture Partners and Sequoia China; it has secured around USD 100 million since its inception in January 2016. The team has been adopting deep learning technology broadly in the medical imaging field.

The firm was involved in an early victory in this complex battle: for the first time since the emergence of the new virus in late 2019, the number of new suspected coronavirus cases in China started to drop, over two consecutive days, on December 31 and January 1, 2020 - mostly driven by faster diagnostic solutions. PCR diagnostics had shown that it could play a crucial role. 

Editor: Luke Sheehan

Enterprise Information

Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
CATEGORIES: Healthcare
Last Funding Type
Series C
Number of Employees
50-100
Number of Funding Rounds
4
Total Funding Amount
84.10M

Enterprise Information

InferVision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
CATEGORIES: Healthcare
Last Funding Type
Series C
Number of Employees
50-100
Number of Funding Rounds
4
Total Funding Amount
84.10M

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers